R

Recursion Pharmaceuticals

486 employees

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Drug Repurposing
Artificial Intelligence
Diseases of Aging
Rare Diseases
Inflammation
Pharmaceutical
Phenomics
Machine Learning
Immuno-oncology
Drug Discovery
artificial intelligence
Therapeutics
Software
Pharmaceuticals

Date founded

2013

Funding rounds raised

Total raised

$239M

from 35 investors over 35 rounds

R

Recursion Pharmaceuticals raised $150M on October 25, 2022

Investors: Laurion Capital Management LP, Baillie Gifford and The Invus Group

R

Recursion Pharmaceuticals raised $239M on September 9, 2020

Investors: Laurion Capital Management LP, Two Sigma Ventures, Intermountain Ventures, Obvious Ventures, Samsara BioCapital, Felicis Ventures, Lux Capital and Leaps by Bayer

R

Recursion Pharmaceuticals raised $121M on July 15, 2019

Investors: Obvious Ventures, Felicis Ventures, Lux Capital, Two Sigma Ventures, Menlo Ventures and University of Minnesota

R

Recursion Pharmaceuticals raised undisclosed on February 8, 2019

Investors: GRIDS Capital

R

Recursion Pharmaceuticals raised $21M on June 5, 2018

Investors: Square 1 Bank

R

Recursion Pharmaceuticals raised $546K on May 7, 2018

Investors: Bill & Melinda Gates Foundation

R

Recursion Pharmaceuticals raised undisclosed on February 12, 2018

Investors: Advantage Capital and Necessary Ventures

R

Recursion Pharmaceuticals raised $60M on October 4, 2017

Investors: Menlo Ventures, Lux Capital, Felicis Ventures, Obvious Ventures, Two Sigma Ventures, CRV and Data Collective

R

Recursion Pharmaceuticals raised $4M on February 7, 2017

Investors: Square 1 Bank

R

Recursion Pharmaceuticals raised $2.2M on November 22, 2016

Investors: Data Collective, Lux Capital, AME Cloud Ventures, Felicis Ventures and Obvious Ventures

FAQ